Zepbound® Savings Card & Cost Guide (2026)

What is Zepbound?

Zepbound® (tirzepatide) is a prescription dual GIP/GLP-1 receptor agonist manufactured by Eli Lilly. It is FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) who have at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea. It is also approved to reduce the risk of obstructive sleep apnea events in adults with moderate-to-severe OSA and obesity.

Who uses Zepbound?

• Adults with obesity (BMI ≥ 30) — As an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management.
• Adults with overweight (BMI ≥ 27) plus a weight-related condition — Including high blood pressure, dyslipidemia, type 2 diabetes, cardiovascular disease, or obstructive sleep apnea.
• Adults with moderate-to-severe obstructive sleep apnea and obesity — Zepbound is approved to reduce the frequency of OSA events alongside weight reduction.

You administer Zepbound yourself at home via a once-weekly subcutaneous injection using a prefilled single-dose pen. The starting dose is 2.5 mg weekly for 4 weeks, then increased to 5 mg weekly. After that, your doctor may increase the dose in 2.5 mg increments every 4 weeks up to a maximum of 15 mg weekly. Available doses are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.

What Does Zepbound Cost Without Insurance?

The sticker price for Zepbound is among the highest in the weight loss medication category. If you are paying out of pocket at a standard pharmacy without any discount program, you are looking at a significant monthly expense. But unlike most specialty medications, Zepbound offers a unique cash-pay pathway that cuts the retail price nearly in half.

Why is Zepbound so expensive?

• Novel mechanism of action: Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist. Developing a new class of biologic requires billions in research and clinical trials, and Eli Lilly prices accordingly.
• No generic or biosimilar exists: As of 2026, no FDA-approved generic or biosimilar for tirzepatide is available. The only competition is other branded GLP-1 medications like Ozempic with different active ingredients.
• Many insurance plans exclude weight loss drugs: This is the single biggest barrier to affordability. Unlike diabetes medications, anti-obesity medications are frequently excluded from formularies entirely — meaning the plan simply refuses to pay for them at any tier. This is not a prior authorization issue; it is a categorical exclusion.
• High demand, limited formulary adoption: The extraordinary clinical results from SURMOUNT trials (up to 22.5% body weight loss) have driven massive demand, but insurance adoption has lagged behind patient interest.

To understand how copay cards work in general — and how they compare to GoodRx, patient assistance programs, and Medicare options — see our complete guide: How Pharma Copay Cards Work.

The Zepbound Savings Card

Eli Lilly offers the Zepbound Savings Card, which can dramatically reduce your monthly cost if you have commercial health insurance that covers the medication.

What you can save

• Pay as little as $25 per month for your Zepbound prescription.
• The savings card bridges the gap between what your insurance pays and a manageable out-of-pocket cost.
• Terms and maximum benefit amounts are set by Eli Lilly and may change — always verify current details at zepbound.lilly.com/savings.

Who qualifies?

• You must have commercial (private) health insurance — employer-sponsored, individual marketplace, or similar.
• Your insurance plan must cover Zepbound. The savings card reduces your out-of-pocket cost on a covered prescription — it cannot make an uncovered drug covered.
• You must be a U.S. resident and meet the program's terms and conditions.
• You must not be enrolled in Medicare, Medicaid, CHIP, TRICARE, or any other government-funded health program.

If your insurance doesn't cover Zepbound: the cash-pay program

This is where Zepbound stands apart from most specialty medications. If your insurance plan excludes anti-obesity medications — which is common — Eli Lilly offers a cash-pay program at approximately $550 per month. This is available through participating pharmacies, does not require insurance coverage or prior authorization, and can be used by any eligible U.S. adult with a valid prescription.

The cash-pay option is not a discount card or a coupon — it is a separate pricing pathway offered directly by Lilly. Check current pricing and eligibility at zepbound.lilly.com/savings.

Key program details

• The savings card must be renewed periodically — check your card for expiration dates and set a reminder.
• The copay card applies to your out-of-pocket cost (copay, coinsurance, or deductible) as billed by your pharmacy.
• The savings card is not valid if Zepbound is not covered by your insurance plan. If your plan excludes it, the cash-pay program is your alternative.
• Available at participating retail and specialty pharmacies — Zepbound can be filled at many retail pharmacies (unlike some specialty-only biologics), but always confirm card acceptance before your first fill.

Insider tip: Pharmacies do not always automatically apply your savings card. Provide the card number proactively at each fill and ask the pharmacist to confirm it was processed before you pay. The difference between "card applied" and "card not applied" can be over $1,000.

Step-by-Step: How to Get the Zepbound Savings Card

The biggest obstacle for Zepbound is not enrollment — it is finding out whether your insurance covers it in the first place. Start there, because it determines your entire path.

1. Check whether your insurance covers Zepbound at all

   Before anything else, call your insurer's pharmacy benefits line (the number on the back of your card) and ask: "Is Zepbound (tirzepatide) on my formulary for weight management?" Many plans exclude anti-obesity medications entirely — this is different from requiring prior authorization. If Zepbound is excluded, jump to Step 6 for the cash-pay path. If it is covered (even at a high tier), continue below.

2. Get your Zepbound prescription and start the prior authorization

   Ask your doctor to prescribe Zepbound and submit a prior authorization to your insurance. The PA for Zepbound typically requires documentation of your BMI, weight-related comorbidities, and previous weight management attempts (diet, exercise, and possibly other medications). PA processing usually takes 1–4 weeks. Denials on first submission are common — this does not mean the process is over.

3. Enroll in the Zepbound Savings Card program

   Visit zepbound.lilly.com/savings or call 1-800-545-6962 (Eli Lilly). Have your insurance card ready. Complete the enrollment — you will need your name, insurance details, and prescribing doctor's information. You can also ask your doctor's office to enroll you during your visit.

4. Save your savings card details

   After enrollment, Lilly will provide your savings card digitally or by mail. Save the card number, BIN, PCN, and group number somewhere accessible — you will need to provide them at every fill. Most pharmacies accept a screenshot or digital card on your phone.

5. Confirm PA approval and fill your prescription

   Once your insurance approves the prior authorization, contact your pharmacy to fill the prescription. Provide your savings card number and confirm the final price before paying. Your cost should be $25 or close to it. If it is higher, ask the pharmacist: "Was the manufacturer savings card applied to this fill?"

6. If your plan excludes Zepbound: use the cash-pay program

   If your insurance does not cover Zepbound, you do not need prior authorization. Visit zepbound.lilly.com/savings to enroll in the cash-pay option at approximately $550/month. This is processed through participating pharmacies and is available to any eligible U.S. adult with a valid prescription. No insurance involvement is required.

7. Renew your card and re-check coverage annually

   Savings card enrollment terms may change. Set a reminder to re-check your card status, and during open enrollment, verify whether your insurance has added or dropped anti-obesity medication coverage for the coming year. Coverage for weight loss drugs is expanding — your plan may add Zepbound coverage that was not available when you first enrolled.

Medicare, Medicaid & Uninsured: Your Options

If the Zepbound Savings Card is not available to you — because you have Medicare, Medicaid, or no insurance — there are still paths forward. They require more effort, but they exist.

Why the savings card does NOT work with Medicare

Federal anti-kickback law (42 U.S.C. § 1320a-7b) prohibits drug manufacturers from offering copay assistance to patients enrolled in any government health program — including Medicare Part D, Medicaid, CHIP, TRICARE, and VA benefits. This applies to every manufacturer copay card for every drug.

But for Zepbound, there is an additional obstacle: Medicare generally does not cover anti-obesity medications. Medicare Part D has historically excluded weight loss drugs from coverage. While legislative efforts are underway to change this (the Treat and Reduce Obesity Act has been proposed repeatedly), as of 2026 most Medicare Part D plans do not cover Zepbound. This means there is often no insurance claim for a copay card to apply to, even if the legal restriction were removed.

Uninsured or underinsured patients: your action plan

How to apply for Lilly Cares

1. Check eligibility at lillycares.com or call 1-800-545-6962. Income limits apply and are reviewed based on the federal poverty level.
2. Gather required documents: proof of income (most recent tax return, W-2, or Social Security benefit statement), proof of U.S. residency, and evidence that you are uninsured or that your insurance does not cover Zepbound (denial letter or formulary exclusion documentation).
3. Your doctor completes their section of the application — including the prescription details and a medical statement. Most weight management or primary care offices are familiar with PAP applications.
4. Submit the application by fax, mail, or through the online portal. Processing typically takes 5–15 business days. If approved, medication is shipped to your doctor's office or directly to you.
5. Renewal is required periodically. Lilly Cares will send a renewal notice, but set your own reminder well before expiration.

The cash-pay alternative

For patients who do not qualify for Lilly Cares based on income, or who prefer not to go through the PAP application process, the Lilly cash-pay program at approximately $550/month remains available regardless of insurance status. This is significantly less than the ~$1,060 retail price and does not require prior authorization or insurance involvement of any kind.

Other resources

• NeedyMeds.org: Free, independent database of all manufacturer assistance programs. Search "tirzepatide" or "Zepbound" at needymeds.org.
• Patient Advocate Foundation: Offers co-pay relief grants and case management for patients with chronic conditions. Apply at patientadvocate.org.
• Obesity Action Coalition: Patient advocacy organization that provides resources for access to obesity treatment, including insurance coverage toolkits. Visit obesityaction.org.
• ACA Marketplace with subsidies: If you are uninsured and your income qualifies, ACA marketplace plans at healthcare.gov may offer affordable coverage. Specifically look for plans that include anti-obesity medications on their formulary — not all do.

What to Do at the Pharmacy (If Something Goes Wrong)

Even after you have enrolled and done everything correctly, pharmacy issues are common with Zepbound. The most frequent problems involve the savings card not being applied, prior authorization delays, stock shortages, and outright coverage denials. Every one of these is fixable if you know what to ask.

If the price is still high ($200+ instead of $25)

The most likely explanation is that your savings card was not applied to the transaction. Ask the pharmacist directly: "Can you reprocess this fill with my Zepbound manufacturer savings card?" Provide the card number, BIN, PCN, and group number. If they say the card was applied, ask them to confirm the exact amount the card covered — there may be a benefit cap you have reached.

If the savings card is rejected

This usually points to an insurance-side issue, not a card problem. The most common causes: your prior authorization expired or was never approved, or your insurance plan does not actually cover Zepbound (the savings card cannot apply to an uncovered drug). Ask the pharmacist: "Is my insurance showing active, approved coverage for this drug?" If coverage is the issue, you may need to switch to the cash-pay program or restart the PA process through your doctor.

If the pharmacy is out of stock

Supply constraints for Zepbound have occurred periodically due to high demand. If your pharmacy does not have your dose in stock, ask: when they expect the next shipment, whether a different dose strength is available (your doctor may be able to adjust temporarily), and whether another pharmacy location has stock. You can also check zepbound.lilly.com for supply updates. Do not accept a substitution with a compounded product — see the compounding warning below.

If your insurance denies coverage entirely

Coverage denials for anti-obesity medications are more common than for most drug categories. If your plan does not cover Zepbound, the savings card cannot be used. But a denial does not have to be the end:

• Ask your doctor to submit a formulary exception request with a letter of medical necessity documenting your BMI, comorbidities, and previous weight management attempts.
• If denied on first appeal, request an external review by an independent third party.
• While appealing, use the cash-pay program at ~$550/month to stay on therapy — gaps in treatment can reset your weight loss progress.
• During open enrollment, evaluate plans that do cover anti-obesity medications. Coverage for this category is expanding year over year.

If you already paid full retail price

Call your pharmacy and ask: "Can you reverse and rebill my last Zepbound fill with my savings card?" Most can do this within 14 days of the original transaction. If the pharmacy cannot help, contact Lilly directly at 1-800-545-6962 to ask about retroactive assistance for eligible patients.

Common Mistakes (and How to Avoid Them)

Zepbound has some unique pitfalls that trip up patients more than most medications — largely because the insurance coverage landscape for weight loss drugs is so inconsistent. Avoiding these mistakes can save you hundreds or thousands of dollars.

• Not checking coverage before getting the prescription filled.
  This is the most expensive mistake. Many patients assume their insurance covers Zepbound because it covers other GLP-1 medications. Anti-obesity medications are frequently excluded from formularies entirely. Call your insurer first — before your doctor writes the prescription — and ask specifically whether Zepbound for weight management is on your formulary.
• Confusing Zepbound with Mounjaro.
  Both contain tirzepatide, both are made by Lilly, but they are different products with different NDC numbers, different indications, and different savings programs. A Mounjaro savings card will not work for a Zepbound prescription, and vice versa. Your doctor prescribes one based on your diagnosis — diabetes (Mounjaro) vs. weight management (Zepbound).
• Using compounded tirzepatide instead of FDA-approved Zepbound.
  Compounded tirzepatide products are not FDA-approved and have not been tested for safety, efficacy, or proper dosing. The FDA has issued warnings about contamination risks and dosing inaccuracies in compounded GLP-1 products. If cost is the barrier, use Lilly's cash-pay program or Lilly Cares — not an unregulated compounding pharmacy.
• Giving up after an insurance denial.
  Coverage denials for Zepbound are extremely common on first submission. Many patients accept the denial as final and either pay full price or stop treatment. In reality, appeals with a strong letter of medical necessity succeed more often than you might expect. File at least one appeal before exploring other options.
• Using the savings card with Medicare or Medicaid.
  Federal law prohibits this, period. And for Zepbound specifically, Medicare almost never covers anti-obesity medications. If you are on Medicare, the savings card is both legally unavailable and practically inapplicable. See the cash-pay and Lilly Cares options above.
• Not knowing about copay accumulator policies.
  Some insurance plans use "copay accumulators" — meaning the money the savings card pays on your behalf does not count toward your deductible or out-of-pocket maximum. You could use the card all year and still owe your full deductible. Call your insurer and ask: "Does my plan use a copay accumulator program?" Learn more in our copay accumulator explainer.
• Not exploring the cash-pay program when coverage is denied.
  Many patients do not realize that Lilly's cash-pay program exists as a middle ground — you do not need insurance coverage, and the price (~$550/month) is roughly half the retail cost. It is not cheap, but it is significantly more accessible than $1,060+ per month, and it requires no prior authorization.

Pro Tips to Maximize Your Savings

• Use the cash-pay program as a bridge while appealing coverage.
  If your insurance denies Zepbound, do not wait months for the appeal to resolve before starting treatment. Enroll in the cash-pay program at ~$550/month to begin therapy now, then switch to the savings card if and when the appeal succeeds. Gaps in GLP-1 treatment can mean regaining weight and losing momentum.
• Ask your HR department about anti-obesity medication coverage.
  If you have employer-sponsored insurance and Zepbound is excluded, your HR benefits team may be able to advocate for adding coverage during the next plan renewal. More employers are recognizing obesity treatment as a cost-effective benefit. Some self-insured employers have added GLP-1 coverage after employee requests.
• Enroll in the savings program before your first fill — not after.
  Have your savings card or cash-pay enrollment confirmed before the pharmacy processes your prescription. This prevents an unexpected $1,060 charge and the hassle of trying to reverse it after the fact.
• Compare insurance plans during open enrollment specifically for anti-obesity coverage.
  The landscape for weight loss medication coverage is changing rapidly. When evaluating plans, search the formulary for "tirzepatide" and "Zepbound" specifically. A plan that costs $50 more per month but covers Zepbound can save you $500+ per month versus the cash-pay price. The same strategy works for other specialty drugs like Repatha or Wegovy. Our guide to reducing prescription costs has a full open enrollment cost-comparison checklist.
• Keep records of all weight-related conditions for PA documentation.
  Prior authorization for Zepbound requires documenting weight-related comorbidities. Maintain records of your BMI history, blood pressure, A1C, cholesterol levels, sleep apnea diagnosis, and any prior weight management programs. The more documentation your doctor can include, the stronger the PA submission.
• Verify your prescription specifies Zepbound, not Mounjaro.
  Since both contain tirzepatide, pharmacy systems can occasionally confuse them. Confirm your prescription specifies Zepbound (for weight management) with the correct NDC number. Using the wrong product can cause insurance billing errors and savings card rejections.

Zepbound Savings: Frequently Asked Questions

Related Resources

Navigating Zepbound coverage is harder than it should be — between insurance exclusions, prior authorization hurdles, and the sheer cost of the medication, many patients give up before finding a path that works. If you have made it this far, you already know more than most. The savings card, the cash-pay program, and patient assistance are all real, accessible options — and the right one depends on your situation.